- Home
- AMLX vs BSM Comparison
AMLX vs BSM Comparison
Compare AMLX & BSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | AMLX | BSM |
|---|---|---|
| Founded | 2014 | 1876 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Oil & Gas Production |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.8B | 3.0B |
| IPO Year | 2021 | 2015 |
Fundamental Metrics
Financial Performance| Metric | AMLX | BSM |
|---|---|---|
| Price | $27.97 | $14.90 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 12 | 0 |
| Target Price | ★ $43.00 | N/A |
| AVG Volume (30 Days) | ★ 1.3M | 375.2K |
| Earning Date | 11-09-2026 | 11-02-2026 |
| Dividend Yield | N/A | ★ 8.11% |
| EPS Growth | ★ 65.46 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $380,786,000.00 | ★ $469,919,000.00 |
| Revenue This Year | N/A | $8.06 |
| Revenue Next Year | N/A | $10.52 |
| P/E Ratio | ★ N/A | $12.82 |
| Revenue Growth | ★ 1612.94 | 8.35 |
| 52 Week Low | $10.83 | $12.93 |
| 52 Week High | $41.14 | $15.49 |
Technical Indicators
Market Signals| Indicator | AMLX | BSM |
|---|---|---|
| Relative Strength Index (RSI) | 48.57 | 52.83 |
| Support Level | $26.12 | $14.40 |
| Resistance Level | $28.60 | $15.17 |
| Average True Range (ATR) | 1.31 | 0.20 |
| MACD | 0.17 | 0.01 |
| Stochastic Oscillator | 54.21 | 61.54 |
Price Performance
Historical ComparisonAbout AMLX Amylyx Pharmaceuticals Inc.
Amylyx Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on developing novel therapies for communities with high unmet medical needs. The company has preclinical and clinical development programs in endocrine conditions and neurodegenerative diseases. Its pipeline includes investigational therapies matched with diseases based on mechanistic rationale, clinical outcomes, biomarkers, and preclinical data. The company is currently developing avexitide for Post-Bariatric Hypoglycemia, AMX0035 for Wolfram Syndrome, AMX0114 for Amyotrophic Lateral Sclerosis, and AMX0318 for Post-Bariatric Hypoglycemia and other rare diseases.
About BSM Black Stone Minerals L.P.
Black Stone Minerals LP is an oil and natural gas mineral company. It owns oil and natural gas mineral interests, which makes up the majority of its asset base. Its business is actively managing an existing portfolio of mineral and royalty assets to maximize its value and expanding asset base through acquisitions of additional mineral and royalty interests. The company owns mineral interests in approximately 16.9 million gross acres.